Dr. Guy Chamberland is the CEO of Tetra Bio-Pharma, a leader in drug discovery and development for cannabinoid-based therapeutics. The company has been a partner of Business of Cannabis for our Medical Cannabis Week – specifically about the good work being done in Atlantic Canada. Chamberland joined BofCLive to talk about recently announced agreement with Thorne Research and Onegevity Health to form a new joint venture: CB2 Therapeutics.
Nevada Commission Approves Reform to Police Hiring Rules Regarding Cannabis Offenses in Landmark Vote
Those who have previously been convicted of cannabis offenses in Nevada will now be able to become police officers for...